Aprea Therapeutics Stock Forecast

APRE's stock price has decreased by -64.13% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 analysts polled by S&P Global, Aprea Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $3.30. The average 1-year stock price forecast is 509.31% higher than the current stock price, while the lowest is $1.20 (+121.57%) and the highest is $5.00 (+823.19%).

Price Target: $3.30 (+509.31%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$1.20	$3.30	$3.50	$5.00
Change	+121.57%	+509.31%	+546.23%	+823.19%

Analyst Ratings

The average analyst rating for Aprea Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Aug '26	Sep '26	Oct '26
Strong Buy	2	3	3	3	2	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	4	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kevin DeGeeter Ladenburg Thalmann & Co.	Ladenburg Thalmann & Co.	Buy Initiates $2	Buy	Initiates	$2	+269.28%	Oct 14, 2026
Jason McCarthy Maxim Group	Maxim Group	Buy Reiterates $5	Buy	Reiterates	$5	+823.19%	Aug 14, 2026
Jay Olson Oppenheimer	Oppenheimer	Buy Reiterates $5	Buy	Reiterates	$5	+823.19%	Aug 13, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $1.2	Buy	Reiterates	$1.2	+121.57%	Aug 13, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $7 → $6	Buy	Reiterates	$7 → $6	+1,007.83%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 285.76K

-100.00%

from 285.76K

Revenue Next Year

n/a

EPS This Year

-0.36

from -1.93

EPS Next Year

-0.40

from -0.36

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	583.23K	1.50M	285.76K	-
Revenue Growth	-	-	-	157.63%	-80.98%	-100.00%
Operating Income	-37.45M	-37.37M	-15.47M	-14.32M	-13.23M	-17.03M
Net Income	-37.13M	-112.66M	-14.29M	-12.96M	-12.60M	-16.07M
EPS	-	-	-	-	-1.93	-0.36
Free Cash Flow	-	-	-	-	-	-16.20M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.28
Avg	-0.36
Low	-0.40

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-